Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia

BACKGROUND: Imatinib is a highly effective treatment for chronic myeloid leukemia (CML) that was approved by the Food and Drug Administration in 2001, and thereafter rapidly became front line therapy. This study characterized the prevailing chronic myeloid leukemia therapies in the United States and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wiggins, Charles L., Harlan, Linda C., Nelson, Harold E., Stevens, Jennifer L., Willman, Cheryl L., Libby, Edward N., Hromas, Robert A.
Format: Artigo
Sprog:Inglês
Udgivet: 2010
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913144/
https://ncbi.nlm.nih.gov/pubmed/20670732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2010.03.018
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker